Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

MicroRNA dysregulation in adenoid cystic carcinoma of the salivary gland in relation to prognosis and gene fusion status: a cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Reduced H3K27me3 expression in radiation-associated angiosarcoma of the breast

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Autopsy after transcatheter aortic valve implantation

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Detection of PMS2 Mutations by Screening Hereditary Nonpolyposis Colon Cancer Families from Denmark and Sweden

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Salivary gland carcinomas with unusual presentations

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Inverted papilloma of the conjunctiva

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Adenoid cystic carcinoma (ACC) is among the most frequent malignancies of the salivary gland, and is notorious for its prolonged clinical course characterized by frequent recurrences often years after initial treatment. No molecular marker has been shown to have independent prognostic value in ACC, including characteristic gene fusions involving MYB, MYBL1, and NFIB. MicroRNA has been shown to be associated with clinical outcome in numerous malignancies, including one study of ACC, warranting further validation of this class of markers in this disease. Here, we investigate the prognostic value of microRNA in two ACC cohorts: a training cohort (n = 64) and a validation cohort (n = 120) with microarray and qPCR. In the training cohort, multivariate analysis of microarray data found high expression of hsa-miR-6835-3p to be associated with reduced recurrence-free survival (RFS) (p = 0.016). Measuring the highest ranking microRNAs identified in survival analysis in the same cohort, qPCR identified high expression of hsa-miR-4676 to be associated with reduced overall survival (OS) and high expression of hsa-mir-1180 to be associated with improved RFS. This was not confirmed in the validation cohort, in which qPCR identified high expression of hsa-mir-21, hsa-mir-181a-2, and hsa-mir-152 to be associated with reduced OS and high expression of hsa-miR-374c to be associated with improved RFS. Interestingly, two distinct subsets of ACC separated in microRNA expression irrespective of gene fusion status, but without significant difference in outcome. Collectively, qPCR identified several microRNAs associated with OS and RFS, and different subsets of ACC separated according to microRNA expression, suggestive of ACC being a heterogeneous group of malignancies in its microRNA profile.

Original languageEnglish
JournalVirchows Archiv : an international journal of pathology
Volume473
Issue number3
Pages (from-to)329-340
Number of pages12
ISSN0945-6317
DOIs
Publication statusPublished - Sep 2018

    Research areas

  • Adolescent, Adult, Aged, Aged, 80 and over, Carcinoma, Adenoid Cystic/genetics, Cohort Studies, Female, Gene Fusion, Humans, Male, MicroRNAs/analysis, Middle Aged, Prognosis, Salivary Gland Neoplasms/genetics, Young Adult

ID: 56322931